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Abstract. 
 
De novo biosynthesis of amino acids uses
intermediates provided by the TCA cycle that must be
replenished by anaplerotic reactions to maintain the
respiratory competency of the cell. Genome-wide ex-
pression analyses in 
 
Saccharomyces cerevisiae
 
 reveal
that many of the genes involved in these reactions are
repressed in the presence of the preferred nitrogen
sources glutamine or glutamate. Expression of these
genes in media containing urea or ammonia as a sole ni-
trogen source requires the heterodimeric bZip tran-
scription factors Rtg1 and Rtg3 and correlates with a
 
redistribution of the Rtg1p/Rtg3 complex from a
predominantly cytoplasmic to a predominantly nuclear
location. Nuclear import of the complex requires the
cytoplasmic protein Rtg2, a previously identified up-
stream regulator of Rtg1 and Rtg3, whereas export re-
quires the importin-
 
b
 
-family member Msn5. Remark-
ably, nuclear accumulation of Rtg1/Rtg3, as well as ex-
pression of their target genes, is induced by addition of
rapamycin, a specific inhibitor of the target of rapamy-
cin (TOR) kinases. We demonstrate further that Rtg3 is
a phosphoprotein and that its phosphorylation state
changes after rapamycin treatment. Taken together,
these results demonstrate that target of rapamycin sig-
naling regulates specific anaplerotic reactions by cou-
pling nitrogen quality to the activity and subcellular lo-
calization of distinct transcription factors.
 
Key words: gene expression • metabolism • phosphor-
ylation • rapamycin • signal transduction
 
Introduction
 
Normal cell growth requires that cells adjust their meta-
bolic activity according to nutrient availability and other
environmental cues. Specialized signal transduction mech-
anisms exist that enable cells to perceive and integrate
these cues in order to establish and/or maintain appropri-
ate patterns of gene expression. Understanding how these
pathways function is thus important for understanding
both normal cellular behavior and the underlying basis of
many human diseases, including cancer. One important
signaling pathway used by all eukaryotic cells is the target
of rapamycin (TOR)
 
1
 
 kinase pathway. This pathway was
discovered through the action of the antibiotic rapamycin,
a potent inhibitor of T cell proliferation, which combines
with the small immunophilin FKBP and targets the large,
evolutionarily conserved TOR kinase (Thomas and Hall,
1997; Dennis et al., 1999). Rapamycin inhibits the growth
of a wide variety of cell types and organisms, including the
budding yeast, 
 
Saccharomyces cerevisiae
 
. Yeast contains
two TOR genes, 
 
TOR1
 
 and 
 
TOR
 
2, and the products of
both are inhibited by the rapamcyin/FKBP complex (Heit-
man et al., 1991; Helliwell et al., 1994; Zheng et al., 1995).
Treating yeast cells with rapamycin has several distinctive
effects that mimic nutrient starvation, including inhibition
of protein synthesis, cell cycle arrest at the G1/S boundary,
onset of autophagy, and inhibition of ribosomal biogenesis
(Heitman et al., 1991; Helliwell et al., 1994; Zheng et al.,
1995; Barbet et al., 1996; Noda and Ohsumi, 1998; Zara-
goza et al., 1998; Powers and Walter, 1999).
Recent studies have shown that TOR kinase activity is
essential for the transcription of ribosomal RNA and ribo-
 
somal protein genes, as well as for the modulation of r-pro-
tein gene expression in response to changes in nutrient
sources (Zaragoza et al., 1998; Powers and Walter, 1999).
These results demonstrate that control of gene expression
at the level of transcription represents an important
branch of TOR signaling. This conclusion has been ex-
tended dramatically by results of recent microarray studies
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where the expression of several hundred genes has been
shown to be affected when TOR function is inhibited by
rapamycin (Cardenas et al., 1999; Hardwick et al., 1999).
In addition to genes involved in protein biosynthesis,
many of the affected genes are involved in the glycolytic
pathway, the TCA cycle, and nitrogen metabolism. Thus,
one important role of TOR appears to be the coordination
of the transcription of genes involved in several distinct
nutrient-responsive cellular pathways.
One of the most striking sets of genes affected by rapa-
mycin treatment is composed of genes involved in the use of
different sources of assimilable nitrogen (Cardenas et al.,
1999; Hardwick et al., 1999; C. Kao, T. Powers, P. Walter,
G. Crabtree, and P. Brown, unpublished results). For ex-
ample, a sharp decrease is observed in the expression of
genes involved in the uptake and metabolism of preferred
nitrogen sources, including glutamine and asparagine. In
contrast, a corresponding increase is observed in the ex-
pression of genes involved in the uptake and use of alterna-
tive nitrogen sources, including urea, proline, and allantoin
(a product of purine catabolism). These results establish a
link between TOR signaling and nitrogen metabolism and
suggest that one crucial role of this pathway is to couple ni-
trogen availability to continued cell growth. Moreover,
they are consistent with results from studies of mammalian
cells that demonstrate that TOR signaling is influenced by
amino acid availability (Iiboshi et al., 1999b). Taken to-
gether, these results are particularly relevant given that
levels of preferred nitrogen sources in human cells (e.g.,
glutamine and asparagine) play an important role in the
progression of several diseases, including childhood acute
lymphoblastic leukemia and these levels may be regulated,
at least in part, by TOR (Iiboshi et al., 1999a).
The molecular mechanism by which TOR controls the
expression of several genes involved in nitrogen metabo-
lism, including 
 
GLN1, MEP2
 
, and 
 
GAP1
 
, has been shown
recently to involve regulated changes in the subcellular lo-
calization of the Gln3 transcription factor (Beck and Hall,
1999). Thus, in the presence of preferred sources of nitro-
gen, Gln3 is sequestered in the cytoplasm by association
with the Ure2 protein, a previously identified negative reg-
ulator of Gln3 function. TOR promotes formation of a
Gln3-Ure2 complex by a mechanism that involves inhibi-
tion of the Sit4 phosphatase and that requires the TOR ef-
fector protein Tap42 (Di Como and Arndt, 1996; Beck and
Hall, 1999; Jiang and Broach, 1999). Treating yeast cells
with rapamycin or, alternatively, introducing them into ni-
trogen-poor media, causes Gln3 to become dephosphory-
lated and to dissociate from Ure2, where it then moves
into the nucleus to activate its target genes (Beck and Hall,
1999). Two additional studies suggest that TOR-depen-
dent changes in the phosphorylation of Ure2 are also
important for regulating the stability of the Gln3-Ure2
complex (Cardenas et al., 1999; Hardwick et al., 1999). Ra-
pamycin treatment stimulates nuclear accumulation of two
other transcriptional activators, Msn2 and Msn4, both of
which respond to different sources of cellular stress, in-
cluding carbon source limitation (Beck and Hall, 1999).
Thus, it is likely that additional nutrient-responsive tran-
scription factors will also turn out to be regulated by TOR.
In addition to permeases and degradative enzymes re-
quired for the use of specific nitrogen sources, distinct
 
pathways involved in carbon metabolism are also respon-
sive to nitrogen availability. For example, it has been ob-
served that several genes encoding enzymes involved in
the TCA and glyoxylate cycles are required for glutamate
prototrophy (Ogur et al., 1964, 1965; Kim et al., 1986; Gan-
gloff et al., 1990). These genes include 
 
ACO1
 
, which en-
codes mitochondrial aconitase, and 
 
CIT1
 
 and 
 
CIT2
 
, which
encode mitochondrial and peroxisomal forms of citrate
synthase, respectively (Ogur et al., 1964; Kim et al., 1986;
Rosenkrantz et al., 1986; Gangloff et al., 1990). Moreover,
recent studies demonstrate that expression of these genes
is subject to repression by glutamate (Liu and Butow,
1999). These results reflect the fact that in addition to pro-
viding reduced NADH and FADH2 for mitochondrial
respiration, the TCA cycle is also the source of many bio-
synthetic intermediates, including 
 
a
 
-ketoglutarate, the pri-
mary precursor to glutamate (Stryer, 1995). Thus, in the
absence of exogenously supplied glutamate (or glutamine),
these intermediates must be replaced through additional
anaplerotic reactions to keep the TCA cycle operational
and to maintain the respiratory competency of the cell. Re-
cent studies have demonstrated that glutamate-mediated
inhibition of 
 
ACO1, CIT1
 
, and 
 
CIT2
 
 involves regulation of
the heterodimeric bHLH/Zip transcription factors Rtg1
and Rtg3 (Liu and Butow, 1999). The mechanism by which
these transcription factors are regulated according to ni-
trogen availability, however, is not well understood.
Studies of both prokaryotic and eukaryotic cells empha-
size glutamate and glutamine as important regulators of ni-
trogen metabolism (reviewed by Magasanik, 1992; Merrick
and Edwards, 1995; Marzluf, 1997). Both are used in the
biosynthesis of other amino acids and, as discussed above,
can be readily converted to 
 
a
 
-ketoglutarate for use in the
TCA cycle. Glutamine is also an immediate precursor for
the biosynthesis of nucleotides and other nitrogen contain-
ing molecules, including NAD
 
1
 
, and thus represents a pri-
mary means by which nitrogen is assimilated into cellular
material. Not surprisingly, cells have evolved elaborate
mechanisms to sense the intracellular levels of these amino
acids and to use this information to regulate their uptake
and/or synthesis. Studies of enteric bacteria have revealed
a complex signaling pathway involving a two-component
regulatory system that couples intracellular levels of
glutamine to changes in gene expression (reviewed by
Merrick and Edwards, 1995). Whether TOR signaling re-
sponds specifically to intracellular levels of glutamine and/
or glutamate in eukaryotic cells is presently unknown.
We are interested in understanding further both the
scope and the mechanisms by which gene expression is
modulated according to nitrogen availability in yeast. To-
ward this end, we have explored a novel use of genome-
wide expression analysis by identifying genes that are ex-
pressed differentially when yeast cells are grown in the
presence of two defined nitrogen sources, the primary
source glutamine versus an alternative source, urea. We
find that a surprisingly small number of genes (
 
,
 
40) show
significant differences in their levels of expression under
these two conditions, where each identified gene is either
induced or repressed by glutamine. In addition to Gln3-
dependent target genes, one of the most concise sets of
genes subject to glutamine-mediated repression includes
metabolic genes regulated by the transcription factors
 Komeili et al. 
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Rtg1 and Rtg3. We demonstrate that, like Gln3, Rtg1 and
Rtg3 are regulated by changes in their subcellular localiza-
tion according to available nitrogen and, moreover, that
the TOR kinase pathway plays an essential role in this reg-
ulation. Our data further suggest that glutamine-respon-
sive transcriptional modulation defines a distinct branch of
TOR signaling in yeast.
 
Materials and Methods
 
Strains, Media, and General Methods
 
All strains of 
 
S. cerevisiae
 
 used in this study are listed in Table I. The fol-
lowing culture media was used: YPD (1% yeast extract, 2% peptone, 2%
dextrose); minimal dextrose (MD) (0.8% yeast nitrogen base without
amino acids and ammonium sulfate, pH 5.5, 2% dextrose); synthetic com-
plete dextrose (SCD) (0.7% yeast nitrogen base without amino acids, pH
5.5, 2% dextrose). MD media contained in addition one or more of the
following nitrogen sources: glutamine, glutamate, ammonia, or urea, as in-
dicated in the text, each at 0.2% final concentration. To supplement the
auxotrophic requirements of strains used for the fluorescence microscopy
experiment presented in Fig. 4 (below), required amino acids, adenine,
and uracil were added to MD media at concentrations described by Sher-
man (1991). SCD media was also supplemented with appropriate amino
acids, adenine and uracil as described by Sherman (1991). Yeast cultures
were grown at 30
 
8
 
C for all experiments. Yeast transformations were per-
formed using a DMSO-enhanced lithium acetate procedure (Hill et al.,
1991). Rapamycin (Sigma-Aldrich) was dissolved in DMSO and added to
a final concentration of 0.2 
 
m
 
g/ml unless stated otherwise.
 
Gene Expression Analysis Using cDNA Microarrays
 
Strain S288c was grown with vigorous shaking to 0.5 OD
 
600
 
/ml in 1 liter of
MD media containing appropriate nitrogen sources, as indicated in the
text. Cells were immediately harvested by centrifugation, flash frozen in
liquid nitrogen, and stored at 
 
2
 
80
 
8
 
C. Relative mRNA levels were deter-
mined by hybridizing fluorescently labeled cDNAs to microarrays con-
taining cDNAs representing virtually every yeast open reading frame
(DeRisi et al., 1997; Lashkari et al., 1997). Arrays were produced under
the auspices of J. Derisi at UCSF by a consortium of laboratories affiliated
with the Department of Biochemistry and Biophysics. Primers for amplifi-
cation of the yeast genome were purchased from Research Genetics and
were provided by the laboratory of P. Walter. Arrays were scanned using
a GenePix 4000a Microarray Scanner (Axon Instruments, Inc.) and ana-
lyzed using software provided by the manufacturer. Data were also ana-
lyzed using software available through the web site affiliated with the lab-
oratories of P. Brown and D. Botstein at Stanford University (Stanford,
CA; http://rana.Stanford.EDU/software/). Scatterplots shown in Fig. 2
(below) were constructed using Excel software (Microsoft Corp.). The
complete data set for the nitrogen source experiments presented here will
be made available upon request.
 
Northern Blots
 
Northern-blot analysis was performed as described previously (Powers
and Walter, 1999). DNA probes were generated by PCR using genomic
DNA from strain S288c as template and specific primers (purchased from
Research Genetics) for individual genes (open reading frame, ORF,
names are listed in Table II). Quantitation of blots was performed using a
STORM 860 imaging system (Molecular Dynamics) and analyzed using
software provided by the manufacturer.
 
Plasmid Construction
 
Green fluorescent protein (GFP)–tagged plasmids were constructed by
PCR amplification of the promoter and ORF of 
 
RTG1, RTG2
 
, and 
 
RTG3
 
.
Primers were designed such that 500 base pairs of upstream promoter re-
gion and the entire ORF of each gene were amplified. Each 5
 
9
 
 upstream
primer contained an XhoI restriction endonuclease site and each 3
 
9
 
 down-
stream primer contained an EcoRI restriction endonuclease site immedi-
ately following the stop codon. After digestion with XhoI and EcoRI,
each fragment was introduced in the XhoI and EcoRI sites of pRS316-
GFP, which contains GFP
 
S65T
 
 (Kaffman et al., 1998b). The resulting plas-
mids, pRtg1-GFP, pRtg2-GFP, and pRtg3-GFP produced versions of
Rtg1-Rtg3 that contained GFP
 
S65T
 
 fused to their COOH termini. Plasmid
pRtg1-GFP3, which contains 
 
RTG1
 
 fused in frame with three tandem cop-
ies of GFP
 
S65T
 
, was constructed by replacing the promoter and coding re-
gion of pPHO4-GFP
 
3 
 
(Kaffman et al., 1998b) with the corresponding pro-
moter and coding region of RTG1. pRtg3-zz was constructed by replacing
the GFP in pRtg3-GFP with two Protein A z domains (zz) as described
(Kaffman et al., 1998b). All plasmid-expressed, tagged genes were tested
for their ability to complement the null phenotype of the appropriate de-
letion strains.
 
Construction of Yeast Strains
 
Strains derived from DBY7286 that were deleted for 
 
RTG1
 
 or 
 
RTG3
 
were constructed using standard gene replacement techniques (Rothstein,
1991). The entire coding regions of both genes were replaced with the
URA3 gene from pRS306 (Sikorski and Heiter, 1989). These strains were
used for the experiments presented in Figs. 3 and 6 (below).
Strains derived from DBY8943 that produced versions of Rtg1-Rtg3
tagged at their COOH termini with three copies of the hemagglutinin
(HA) epitope were constructed using the PCR-based method described
by Brachmann et al. (1998) and Longtine et al. (1998). As template for
PCR, we used the plasmid pFA6a-3HA-HIS3MX6 that contained the
 
Schizosaccharomyces pombe
 
 HIS3 homologue (Longtine et al., 1998). The
 
Table I. Strains of S. cerevisiae Used in this Study
 
S288c
 
Mat
 
a
 
 gal2 mal
 
Botstein Lab strain collection*
DBY7286
 
Mata ura3 
 
Botstein Lab strain collection*
PYL037 same as DBY7286, except for 
 
rtg1
 
D
 
::URA3
 
This work
PLY039 same as DBY7286, except for 
 
rtg3
 
D
 
::URA3
 
This work
DBY8943
 
Mata his3
 
D
 
::hisG
 
Botstein Lab strain collection*
PLY047 same as DBY8943, except for 
 
RTG1-3HA:HIS3MX6
 
This work
PLY050 same as DBY8943, except for 
 
RTG3-3HA:HIS3MX6
 
This work
PLY089 same as DBY8943, except for 
 
RTG2-3HA:HIS3MX6
 
This work
JK9-3da
 
Mata leu2-3, 112 ura3-52 rme1 trp1 his4 
 
Barbet et al., 1996
JH11-1c same as JK9-3da, except for
 
 TOR1-1
 
Barbet et al., 1996
PLY079 same as EY0733, except for 
 
TOR1-1, 
 
pRTG1-GFP This work
PLY083 same as EY0735, except for 
 
TOR1-1,
 
 pRTG3-GFP This work
K699
 
Mat
 
a
 
 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 GAL
 
1
 
Nasmyth et al., 1990
EY0733 same as K699, except for 
 
rtg1
 
D
 
::TRP1
 
This work
EY0734 same as K699, except for
 
 rtg2
 
D
 
::TRP1
 
This work
EY0735 same as K699, except for 
 
rtg3
 
D
 
::TRP1
 
This work
EY0736 same as K699, except for 
 
msn5
 
D
 
::HIS3
 
This work
EY0744 same as K699, except for 
 
rtg2
 
D
 
::TRP1 msn5
 
D
 
::HIS3
 
This work
 
*See Materials and Methods.
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tagged genes were determined to be functional based on the normal
growth of each resulting strain, PLY047, PLY050, and PLY089, on MD–
ammonia and –urea agar plates. These strains were used for the experi-
ment presented in Fig. 9 A (below).
Strains derived from K699 that were deleted for 
 
RTG1, RTG2
 
, or
 
RTG3
 
 were made using the same PCR-based gene disruption technique
described above, using the 
 
TRP1
 
 gene of 
 
Candida
 
 
 
glabrata 
 
as a selectable
marker (Kitada et al., 1995). Primers used for PCR possessed 40 bases of
homology that corresponded to the 5
 
9
 
 and 3
 
9
 
 ends of the open reading
frame of each target gene. These strains, EY0733, EY0734, and EY0735,
were transformed with an appropriate GFP fusion plasmid, described
above, and used for the fluorescence microscopy experiments presented in
Figs. 4, 5 A, and 7 (below).
MSN5 was deleted from K699 using a HIS3-marked disruption vector,
as described previously (Kaffman et al., 1998a). The 
 
rtg2
 
D 
 
msn5
 
D
 
 strain
was made by mating the 
 
rtg2
 
D
 
 and 
 
msn5
 
D
 
 strains described above and se-
lecting TRP
 
1
 
 HIS
 
1
 
 segregants after sporulation and tetrad dissection. The
resulting 
 
msn5
 
D
 
 and 
 
rtg2
 
D
 
 msn5
 
D
 
 strains, EY0736 and EY0744, respec-
tively, were used for experiments presented in Fig. 8 (below).
 
Strains containing the 
 
TOR1-1
 
 allele combined with either 
 
rtg1
 
D
 
/
pRTG1-GFP or 
 
rtg3
 
D
 
/pRTG3-GFP were constructed using the following
approach. Strains EY0733 and EY0735 were transformed with pRTG1-
GFP or pRTG3-GFP, respectively. The resulting transformants were mated
to strain JH11-1c and diploids were selected by their ability to grow on SCD
agar plates lacking both adenine and uracil. After sporulation, TRP
 
1
 
,
URA
 
1
 
 segregants were isolated and tested for their ability to grow on plates
containing 0.2 
 
m
 
g/ml rapamycin. The resulting selected strains, PLY079 and
PLY083, were used for the experiment shown in Fig. 5 B (below).
All wild-type parental strains used for construction of the above strains
were examined by Northern blot analysis to confirm that expression of the
 
RTG
 
-dependent target genes CIT2 and DLD3 was (a) repressed by pre-
ferred nitrogen sources, and (b) induced by rapamycin treatment.
 
Fluorescence Microscopy
 
For all microscopy experiments, cells were freshly transformed with plas-
mids that expressed appropriate GFP-fusion proteins. Cells were first
grown overnight in SCD media that lacked uracil to select for plasmid
 
Table II. Summary of Nitrogen-regulated Genes Identified by Microarray Analysis
 
Functional class ORF Gene Description
Expression
ratio*
 
Genes preferentially expressed in glutamine
Transporters YDR046C
 
BAP3
 
Amino acid permease 12.5
YBR068C
 
BAP2
 
Amino acid permease 17.4
YCL025C
 
AGP1
 
Amino acid permease 12.3
YBR069C
 
VAP1
 
Amino acid permease 3.5
YOL020W
 
TAT2
 
Tryptophan permease 3.4
YDR508C
 
GNP1
 
Glutamine permease 3.1
YGR055W
 
MUP1
 
Methionine permease 10.6
YER064C Unknown Putative small molecule transporter 3.3
YNL065W Unknown Putative small molecule transporter 3.2
Miscellaneous YNL160W
 
YGP1
 
Stationary phase secreted glycoprotein 9.4
YCR021C
 
HSP30
 
Plasma membrane heat shock protein 4.6
YFL014W
 
HSP12
 
Glucose and lipid heat shock protein 3.8
Genes preferentially expressed in urea
 
DAL 
 
cluster group YIR027C
 
DAL1
 
Allantoinase 14.2
YIR029W
 
DAL2
 
Allantoinase 12.7
YIR032C
 
DAL3
 
Ureidoglycolate hydrolase 5.3
YIR028W
 
DAL4
 
Allantoin permease 18.8
YJR152W
 
DAL5
 
Allantoate and ureidosuccinate permease 17.8
YIR031C
 
DAL7
 
Glyoxysomal malate synthase 34.4
YKR034W
 
DAL80
 
Repressor of GLN3 function 4.3
Transporters YKR039W
 
GAP1
 
General amino acid permease 5.3
YNL142W
 
MEP2
 
Ammonia permease 17.3
YBR294W
 
SUL1
 
Sulfate transport protein 4.2
YHL016C
 
DUR3
 
Urea permease 35.9
YLR348C
 
DIC1
 
Mitochondrial dicarboxylate carrier 3.3
YPL265W
 
DIP5
 
Dicaroboxylic amino acid permease 7.5
Metabolism/Enzymes YBR208C
 
DUR1,2
 
Urea amidolyase 5.4
YLR142W
 
PUT1
 
Proline oxidase 10.6
YPR035W
 
GLN1
 
Glutamine synthetase 6.9
YNL117W
 
MLS1
 
Malate synthase 1 4.8
YGL062W
 
PYC1 Pyruvate carboxylase 1 7.5
YLR304C ACO1 Aconitate hydratase 9.5
YNL037C IDH1 Isocitrate dehydrogenase 1 7.7
YOR136W IDH2 Isocitrate dehydrogenase 2 8.4
YCR005C CIT2 Peroxisomal citrate synthase 10.5
YEL071W DLD3 D-Lactate dehydrogenase 3 9.1
Prototrophic strain S288c was grown to 0.5 OD600/ml in 1 liter minimal dextrose media containing 0.2% glutamine or 0.2% urea as sole nitrogen sources. PolyA mRNA was isolated
and used to prepare cDNAs that were fluorescently labeled with either Cy3 or Cy5 fluorescent dyes. Samples were mixed and applied to DNA microarrays containing .6,200
individual yeast genes and analyzed using a microarray laser reader. Shown are the results of three independent experiments. In two of these experiments, each sample was labeled
with Cy3 as well as Cy5, generating a total of five independent microarrays used for analysis. Listed genes displayed a mean difference ratio of 3.0 or greater in each of the five
microarrays. Several genes known from previous studies to be regulated by glutamine did not meet these strict criteria, including PUT4, ARG3, CAR1, and ASP3,4. Thus, this list
is likely to represent an underestimate of the total number of glutamine-regulated genes. Gene names and descriptions were obtained from the SGD (http://genome-
www.stanford.edu/Saccharomyces) and YPD (http://www.proteome.com/databases/index) databases.
*Genes preferentially expressed in glutamine (glutamine vs. urea), genes preferentially expressed in urea (urea versus glutamine).
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maintenance. To lower the background auto fluorescence of the parent
strain, additional adenine and tryptophan were added to a final concentra-
tion of 0.005%. Cells were then diluted to 0.005 OD600/ml in media appro-
priate for each experiment, as indicated in the text, and were examined di-
rectly by fluorescence microscopy when they reached 0.5 OD600/ml.
Rapamycin was added to a final concentration of 1.0 mg/ml for microscopy
experiments presented in the figures. Identical results were also obtained
at the lower rapamycin concentration of 0.2 mg/ml. All images document-
ing GFP localization were collected on an microscope with a 1003 objec-
tive (BX60; Olympus) and recorded with a CCD camera (Photometrics)
using identical settings for each experiment and an average exposure time
of 1.0–1.5 s.
Preparation of Cell Extracts and Western Blot Analysis 
For detection of Rtg1-Rtg3 by immunoblotting, cells were grown in ap-
propriate media, as described in the text, to 0.5 OD600/ml, treated with ra-
pamycin where indicated, and harvested directly. Extracts were prepared
as described previously (Kaffman et al., 1998b). As Rtg3 proved to be rel-
atively unstable in cell extracts, even in the presence of protease inhibi-
tors, fresh extracts were prepared for each experiment and were never
frozen. To detect Rtg1-HA3, Rtg2-HA3, and Rtg3-HA3, 1–2 mg of extract
was separated by SDS-PAGE as described (Kaffman et al., 1998b). Anti–
HA Western blots were performed using affinity-purified 12CA5 antibod-
ies (Babco). Rtg3-zz was immunoprecipitated using IgG-Sepharose beads
as described (Amersham Pharmacia Biotech). For phosphatase experi-
ments, immunoprecipitated Rtg3-zz was washed with IgG buffer and
lambda phosphatase buffer (New England Biolabs, Inc.). Samples were
split in half and beads were resuspended in 100 ml of lambda phosphatase
buffer with 2 mM MnCl2. Approximately 800 U of lambda protein phos-
phatase were added to one of the two samples and the reactions were in-
cubated for 30–45 min at 308C. Samples were eluted by boiling the beads
in 23 SDS sample buffer for 3 min and analyzed using anti–zz rabbit poly-
clonal antisera as described (Kaffman et al., 1998b).
Results
Identification of Nitrogen-regulated Genes
We used genome-wide gene expression analysis to com-
pare mRNA levels following the growth of yeast cells in
the presence of two distinct sources of assimilable nitro-
gen, glutamine and urea. Whereas glutamine is used di-
rectly in the biosynthesis of several nitrogen-containing
compounds, urea must first be degraded, via a bifunctional
enzyme encoded by the DUR1,2 gene, to ammonia and
carbon dioxide before the ammonium ion can be incorpo-
rated into glutamate and glutamine (Sumrada and Cooper,
1982). We chose urea in part because we observed that the
prototrophic strain S288c grew with a similar doubling
time of z110 min in minimal dextrose media containing
either glutamine (MD-glutamine) or urea (MD-urea) as a
sole source of nitrogen. This was in contrast to several
other alternative nitrogen sources that we tested, including
arginine and proline, which resulted in reduced growth
rates (data not shown). Thus we reasoned that any ob-
served differences in gene expression would be restricted
to the use of glutamine and urea as nitrogen sources,
rather than secondary effects due to differences in growth
rate. Accordingly, S288c was grown to mid-log phase in
MD-glutamine or MD-urea and PolyA mRNA was iso-
lated. Fluorescently labeled cDNAs were then prepared
and applied to DNA microarrays that contained nearly ev-
ery yeast open reading frame (DeRisi et al., 1997; Lashkari
et al., 1997).
Of the more than 6,200 genes examined, a surprisingly
small number (,40) displayed differences in expression
threefold or greater under these two nitrogen conditions;
12 were expressed preferentially in MD-glutamine and 24
were expressed preferentially in MD-urea (Table II). We
confirmed these results for a representative number of
genes directly by Northern blot analysis (Fig. 1). The ma-
jority of genes that were expressed better in MD-
glutamine encoded permeases specific for amino acids as-
sociated with rich nutrient conditions, including GNP1
and TAT2, which encode high affinity permeases specific
for glutamine and tryptophan, respectively (Zhu et al.,
1996; Beck et al., 1999). In contrast, genes expressed pref-
erentially in MD-urea could be grouped into one of three
general classes: (a) transport permeases specific for poor
nitrogen conditions, including DUR3, which encodes urea
permease; (b) the majority of the DAL genes, which are
involved in the uptake and catabolism of allantoin (Coo-
per et al., 1979; Cox et al., 1999); and (c) metabolic en-
zymes, including several associated with the citric acid and
glyoxylate cycles (Table II). Given the relatively small
number of genes identified in this experiment, these re-
sults suggest that a limited number of regulatory pathways
are likely to be involved in the differential use of these two
nitrogen sources.
To extend the above results, we determined the relative
expression of a representative number of genes following
the growth of cells in media containing one of two other
preferred nitrogen sources, glutamate and ammonia. In
general, the pattern of expression produced by cells in
MD-glutamate was similar to that produced in MD-
glutamine, particularly for the genes involved in the TCA
and glyoxylate cycles (Fig. 1 B, compare lanes 1 and 2).
Several differences were also observed, however. For ex-
ample, GLN1, which encodes glutamine synthetase, was
expressed in MD-glutamate but not in MD-glutamine
(Fig. 1 C, compare lanes 1 and 2). This result demonstrates
the extreme selectivity in gene expression that exists ac-
cording to the precise nitrogen source provided (Ma-
gasanik, 1992).
Very few differences in gene expression were observed
when ammonia and urea were compared, one of the most
notable being DUR3 (Fig. 1 C, compare lanes 3 and 4). In-
deed, microarray analysis revealed that ,10 genes were
expressed differently when cells were grown in media con-
taining each of these two nitrogen sources (T. Powers, un-
published results). These results were somewhat surprising
given that ammonia is known to display many of the same
regulatory properties as glutamine and glutamate (Ma-
gasanik, 1992). One likely explanation for this result is that
some strains of S. cerevisiae harbor mutations that affect
ammonia-dependent regulation of certain genes (Cour-
chesne and Magasanik, 1983). The precise molecular basis
for this observation has yet to be clarified.
Demonstration of Glutamine as a Global Regulator of 
Gene Activity
The results of the above microarray experiment revealed
the scope of genes whose expression differed significantly
in the presence of glutamine versus urea. This experiment
could not distinguish, however, whether these differences
resulted from the stimulation or repression of gene activity
by either nitrogen source. We reasoned that we could ad-
dress this issue using microarrays by pair-wise compari-
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sons of cultures grown in the presence of one versus both
nitrogen sources. The logic here was that a given gene
should display the same level of expression (i.e., have a ra-
tio z1.0) if the activating (or repressing) nitrogen source
was present in the two samples being compared. Accord-
ingly, we compared mRNA levels from cells grown in the
following media: MD-glutamine, MD-urea, and MD-
glutamine1urea. The results of this experiment are shown
in the form of scatter plots in Fig. 2.
When mRNA levels from cells grown in MD-glutamine
and MD-urea were compared, most genes appeared as
points along a diagonal with a slope of z1.0 and corre-
sponded to genes expressed similarly under the two condi-
tions (Fig. 2 A). A characteristic number of points fell
both above and below this diagonal and corresponded to
genes (reported in Table II) that were preferentially ex-
pressed in glutamine or urea, respectively (Fig. 2 A). This
pattern of expression was remarkably similar when cells
grown in MD-urea and MD-glutamine1urea were com-
pared, indicating that the presence of urea in both cultures
did not significantly change the relative expression of any
gene (Fig. 2, compare A and B; note that the plot in B ap-
pears as the reciprocal of the plot in A due to the arrange-
ment of axes). In dramatic contrast, when MD-glutamine
and MD-glutamine1urea samples were compared, essen-
tially all points collapsed onto the diagonal, demonstrating
the dramatic effect by glutamine on gene expression (Fig.
1 C). From these results, we conclude that essentially all
differences in gene expression observed in these experi-
ments result from glutamine acting as both an activator
and a repressor of gene activity. This conclusion was con-
firmed for a number of representative genes by Northern
blotting (Fig. 1, lanes 5–7) and is consistent with the dem-
onstrated role of glutamine as an important regulator of
nitrogen-dependent gene expression (Magasanik, 1992). 
RTG-dependent Gene Expression: An Interface between 
Carbon and Nitrogen Metabolism
Many of the differences in gene expression observed in the
preceding experiments were likely to reflect altered meta-
bolic needs as cells use distinct nitrogen sources. For
example, de novo biosynthesis of amino acids requires
intermediates provided by the TCA cycle, primarily ox-
aloacetate and a-ketoglutarate, that must be replaced
Figure 1. Examples of differences in gene expression during growth of yeast cells in the presence of different sources of assimilable ni-
trogen. Strain S288c was grown to mid-log phase in MD media containing the indicated nitrogen sources. Total mRNA was isolated and
Northern blot analysis was performed, probing for the specified mRNAs. (A) Control transcripts showing no significant differences un-
der the conditions tested. (B) Transcripts displaying similar levels of expression in MD-glutamine and MD-glutamate. (C) Transcripts
displaying more complex patterns of expression. 
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through anaplerotic reactions to maintain the respiratory
competency of the cell (Stryer, 1995). These reactions in-
clude production of succinate via the glyoxylate cycle and
formation of oxaloacetate directly from pyruvate, a reac-
tion catalyzed by pyruvate carboxylase, encoded by the
PYC1 gene in yeast (Stucka et al., 1991; Walker et al.,
1991). Remarkably, it is precisely the genes encoding these
enzymes, as well as several TCA cycle enzymes that cata-
lyze steps leading to the formation of a-ketoglutarate,
namely ACO1, IDH1, and IDH2, that we found to be re-
pressed by glutamine (or glutamate) (Figs. 1 B and 3 A,
and data not shown). Thus, one physiological response of
cells growing in the absence of these nitrogen sources was
increased expression of genes involved in these anaple-
rotic reactions. We decided to explore this regulation in
greater detail.
Two distinct transcriptional regulatory complexes,
namely HAP and RTG, have been demonstrated to regu-
late expression of ACO1, IDH1, and IDH2 (Forsburg and
Guarente, 1989; McNabb et al., 1995; Liu and Butow,
1999). We reasoned that the RTG genes were most likely
to be involved in nitrogen-regulated expression of these
genes for the following reasons: (a) HAP gene control is
subject to repression by glucose, which was used as a car-
bon source in all our experiments; (b) the RTG genes
are responsible for regulating several other glutamine-
repressed genes identified in our microarray experiments,
including CIT2 and DLD3; (c) rtg mutants are reported to
be glutamate auxotrophs, a phenotype that would be con-
sistent with our observations (Liu and Butow, 1999). The
RTG family consists of three genes, RTG1–3, where
RTG1 and RTG3 both encode members of the bZip fam-
ily of transcription factors that form a heterodimeric com-
plex (Jia et al., 1997; Rothermel et al., 1997). In agreement
with results from a previous study (Liu and Butow, 1999),
strains containing single deletions in either RTG1 or
RTG3 grew very poorly on plates containing urea or
ammonia as sole nitrogen sources, yet grew normally
on plates containing glutamine or glutamate (data not
shown).
To determine directly whether the RTG transcription
factors were required for regulated expression of the
Figure 2. Glutamine is both a global activator and repressor of gene expression. Scatter plots show pairwise comparisons of gene ex-
pression profiles of S288c cells grown in the presence of glutamine, urea, or glutamine 1 urea. (A) MD-glutamine versus MD-urea. (B)
MD-urea versus MD-glutamine 1 urea. (C) MD-glutamine versus MD-glutamine 1 urea. (D) Control experiment comparing MD-
glutamine with itself. For each plot, the x axis depicts cDNA samples labeled with Cy5 dye and the y axis depicts samples labeled with
Cy3 dye.
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above metabolic genes under our experimental conditions,
we performed the following nutrient-shift experiment.
Wild type, rtg1D, or rtg3D cells were grown in MD-
glutamine to early log phase, and were then transferred ei-
ther to fresh MD-glutamine (as a control) or to MD-urea.
Total RNA was isolated and mRNA levels of a represen-
tative number of these genes were analyzed by Northern
blotting and normalized to actin mRNA levels (Fig. 3 B).
As expected, each gene examined displayed increased ex-
pression, relative to actin, when wild-type cells were trans-
ferred to MD-urea but not to MD-glutamine (Fig. 3 B,
compare lanes 1 and 2 with 3). In contrast, no increased
expression of ACO1, IDH1, IDH2, CIT2, or DLD3 was
observed upon transfer of either rtg1D or rtg3D cells to
MD-urea (Fig. 3 B, lanes 6 and 9). Interestingly, PYC1 ex-
pression was increased in each mutant strain in MD-urea
by about half the extent observed in wild-type cells (Fig. 3
B, compare lane 3 with 6 and 9). In addition, similar levels
of expression were observed for MLS1 in both wild-type
and each rtg mutant strains in MD-urea (data not shown).
These latter results demonstrate that factors in addition to
the RTG genes are likely to be involved in the regulated
expression of these two metabolic genes under these con-
ditions and is consistent with previous biochemical and
molecular genetic analyses of RTG-dependent control of
PYC1 expression (Small et al., 1995; Menendez and
Gancedo, 1998). Taken together, these results revealed a
strong correlation between RTG-dependent expression
for a number of metabolic genes and the ability of yeast to
grow using urea as a nitrogen source.
Figure 3. Rtg1 and Rtg3 are required for expres-
sion of distinct metabolic genes in MD-urea. (A)
Summary of metabolic genes (bold) subject to
glutamine-mediated transcriptional repression
(see Table II; note that CIT1 is not listed in Ta-
ble II as its MD-glutamine/MD-urea expression
ratio of z2.0 fell below the cut off value of 3.0
required for listing). Genes depicted were simi-
larly repressed in MD-glutamine and MD-
glutamate, except for GLN1 (see Fig. 1). (B) Ni-
trogen source shift experiment. Wild-type
(S288c), rtg1D (PLY037), and rtg3D (PLY039)
cells were grown in MD-glutamine until 0.5
OD600/ml and were either harvested (lanes 1, 4,
and 7) or transferred to MD-glutamine (lanes 2,
5, and 8) or MD-urea (lanes 3, 6, and 9) media
for 30 min before harvesting. RNA was prepared
and analyzed by Northern blotting and probed
for the specified mRNAs. 
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Nitrogen-dependent Changes in the Subcellular 
Localization of Rtg1 and Rtg3
We wanted to understand the mechanism by which Rtg1
and Rtg3 activity is regulated. No significant differences
were observed in the steady state levels of either RTG1 or
RTG3 mRNAs, nor of Rtg1 or Rtg3 proteins in MD-
glutamine versus MD-urea, suggesting that their activity
was regulated post-translationally (data not shown; see be-
low). Recently, a number of nutrient-responsive transcrip-
tion factors have been shown to be regulated at the level
of nuclear transport (reviewed in Beck and Hall, 1999;
Kaffman and O’Shea, 1999). We therefore tested whether
Rtg1 and/or Rtg3 might be similarly regulated in this man-
ner. Toward this end, we fused the coding region of GFP
in frame to the 39 ends of both RTG1 and RTG3 to pro-
duce fusion proteins, termed Rtg1-GFP and Rtg3-GFP.
Fluorescence microscopy was then used to examine the
subcellular localization of Rtg1-GFP and Rtg3-GFP in
cells grown under different nitrogen conditions. Control
experiments demonstrated that each fusion protein com-
plemented the glutamine auxotrophy of its respective rtg1
or rtg3 deletion strain (data not shown).
Both Rtg1-GFP and Rtg3-GFP appeared predominantly
cytoplasmic when cells were grown in MD-glutamine (Fig.
4, left). Similar results were obtained when glutamate was
used instead as a nitrogen source (data not shown). In con-
trast, both proteins were concentrated in the nucleus when
cells were grown in MD-urea (Fig. 4, right). Also, in close
agreement with the transcriptional responses described
above, both Rtg1-GFP and Rtg3-GFP remained cytoplas-
mic when cells were grown in media that contained both
glutamine and urea (data not shown). From these results,
we conclude that RTG-dependent gene activation involves
changes in the subcellular distribution of the Rtg1/Rtg3
complex.
Rtg1 and Rtg3 Activity and Subcellular Localization Is 
Regulated by the TOR Pathway
We wished to identify the signaling pathway(s) that linked
nitrogen quality to the localization of the Rtg1/Rtg3 com-
plex. Here a clue was provided by the fact that many RTG-
dependent target genes become induced when cells are
treated with rapamycin, a specific inhibitor of the TOR ki-
nases (Hardwick et al., 1999; C. Kao, T. Powers, P. Walter,
G. Crabtree, and P. Brown, unpublished observations). Ac-
cordingly, we localized Rtg1-GFP and Rtg3-GFP in cells
Figure 4. Rtg1 and Rtg3 are localized within the nucleus un-
der glutamine-limiting conditions. rtg1D (EY0733) or rtg3D
(EY0735) cells were transformed with pRtg1-GFP or pRtg3-
GFP, respectively, and were grown to 0.5 OD600/ml in MD-
glutamine or MD-urea and examined by fluorescence micros-
copy. Punctate nuclear fluorescence was observed for both
Rtg1-GFP and Rtg3-GFP in MD-urea. The nuclear disposition of
this GFP-based fluorescence was confirmed by its colocalization
with DAPI-stained nuclear DNA (data not shown).
Figure 5. Rtg1 and Rtg3 are localized within the nucleus after ra-
pamycin treatment in a TOR1-dependent manner. (A) rtg1D
(EY0733) or rtg3D (EY0735) cells expressing Rtg1-GFP or Rtg3-
GFP, respectively, were treated with drug vehicle alone (left) or
with 1 mg/ml of rapamycin (right) for 5 min, followed by exami-
nation by fluorescence microscopy. Pronounced nuclear accumu-
lation of both Rtg1-GFP and Rtg3-GFP was observed in cells
treated with rapamycin. (B) The experiment in A was repeated
using cells that carried the dominant rapamycin resistant TOR1-1
allele.
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grown in nitrogen-rich media in both the absence and pres-
ence of rapamycin. As expected, both proteins remained in
the cytoplasm in the absence of rapamycin (Fig. 5 A, left).
In striking contrast, strong nuclear accumulation of both
Rtg1-GFP and Rtg3-GFP was observed within 5 min of ra-
pamycin addition (Fig. 5 A, right). Nuclear accumulation of
these proteins by rapamycin was due specifically to inhibi-
tion of the TOR pathway, since little or no accumulation
was observed when this experiment was repeated using a
strain that contained the dominant rapamycin-resistant
TOR1-1 allele (Fig. 5 B, right). These results demonstrate
that nuclear accumulation of Rtg1 and Rtg3 in rich nitro-
gen media is prevented by a functional TOR pathway.
A prediction of the above results was that inhibiting the
TOR pathway might be sufficient to result in RTG-depen-
dent gene activation. To test this directly, we performed a
time course of rapamycin treatment of wild-type, rtg1D,
and rtg3D cells grown in MD-glutamine, and then analyzed
mRNA levels of several RTG-dependent targets by
Northern blotting. In wild-type cells, each target gene ex-
amined showed increased expression within 15 min after
addition of rapamycin (Fig. 6, compare lanes 1 and 2). The
expression levels of these genes peaked at z30 min and
were comparable with the levels observed in cells grown in
MD-urea (Fig. 6, lane 3; compare with Fig. 3 B, lane 3).
In striking contrast, no induction was observed for any
of these genes when rapamycin was added to rtg1D and
rtg3D cells (Fig. 6 B, lanes 5–12). The sole exception was
PYC1, which showed a level of induction in each mutant
strain of about half that observed in wild-type cells. This
latter result is thus reminiscent of the behavior of PYC1 in
the nutrient shift experiment described above (Fig. 4 B)
and indicates that an additional rapamycin-sensitive regu-
latory factor(s) is involved in the expression of this gene.
As a control, we observed similar induction of two Gln3-
dependent targets, DUR3 and DAL5, in both wild-type
and the rtg deletion strains, demonstrating that the loss of
induction in the rtg mutants is specific for RTG-dependent
targets. The specificity of these results was also confirmed
by an observed decrease in RPL32 mRNA levels in all
strains after rapamycin treatment, as reported previously
(Powers and Walter, 1999). Taken together, these results
directly link TOR activity to both the subcellular localiza-
tion and the activity of the Rtg1/Rtg3 complex.
Interestingly, deletion of the genes encoding the GATA
transcriptional regulators Gln3 and Gat1, whose nucleocy-
toplasmic transport is similarly regulated by TOR, confers
weak resistance to rapamycin (Beck and Hall, 1999). By
contrast, we observed no change in the sensitivity of rtg1D
or rtg3D cells to this drug, in comparison to wild-type cells
(data not shown). Thus, we conclude that rapamycin-
induced expression of RTG-dependent target genes does
not contribute to the toxic effects of this drug on yeast cells.
Regulated Nucleocytoplasmic Transport of Rtg1 and 
Rtg3 Requires All Three RTG Genes
The third member of the RTG gene family, RTG2, en-
codes a cytoplasmic protein that contains an HSP70-like
ATP binding domain and displays homology to certain
bacterial polyphosphatases and phosphatases (Liao and
Butow, 1993; Koonin, 1994). Genetic evidence indicates
that this gene functions upstream of RTG1 and RTG3 and
is essential for expression of RTG-dependent target genes
(Rothermel et al., 1997). We asked whether Rtg2 was in-
volved in TOR-regulated nuclear accumulation of Rtg1
Figure 6. Induction of RTG-dependent target genes
by rapamycin. Wild-type (S288c), rtg1D (PLY037),
and rtg3D (PLY039) cells were grown in MD-
glutamine to 0.5 OD600/ml and were treated either
with drug vehicle (lanes 1, 5, and 9) or with rapamy-
cin for 15 (lanes 2, 6, and 10), 30 (lanes 3, 6, and 9), or
60 (lanes 4, 8, and 12) min. Cells were then harvested
and RNA was prepared and analyzed by Northern
blotting, probing for the specified mRNAs.
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and Rtg3 by monitoring the localization of Rtg1-GFP and
Rtg3-GFP in rtg2D cells, in both the absence and presence
of rapamycin. As in wild-type cells, both proteins were lo-
calized to the cytoplasm in the absence of drug (Fig. 7 A,
left). In contrast, no nuclear accumulation of either protein
was observed after addition of rapamycin (Fig. 7 A, right).
Additional experiments demonstrated that Rtg2 was itself
a cytoplasmic protein and that its localization did not
change after rapamycin treatment (data not shown). Thus,
these results demonstrate that Rtg2 is essential for rapamy-
cin-induced nuclear accumulation of the Rtg1/Rtg3 com-
plex and that it carries out this function in the cytoplasm.
We next determined whether both Rtg1 and Rtg3 were
required for TOR-regulated nuclear transport of the Rtg1/
Rtg3 complex by monitoring the localization of Rtg1-GFP
in rtg3D cells or, alternatively, Rtg3-GFP in rtg1D cells,
both before and after rapamycin treatment. We observed
that Rtg1-GFP remained exclusively cytoplasmic in rtg3D
cells, even after rapamycin addition (Fig. 7 B, top, and
data not shown). Since Rtg1 is a relatively small protein of
177 amino acids, we wanted to exclude the possibility that
the constitutive presence of Rtg1-GFP in the cytoplasm in
rtg3D cells was not due simply to the diffusion of this pro-
tein out of the nucleus after rapamycin treatment. Toward
this end, we fused three tandem copies of the coding re-
gion of GFP to the 39 end of the RTG1 gene to create a
much larger protein, termed Rtg1-GFP3. Control experi-
ments confirmed that this fusion protein was functional
(data not shown). We observed that Rtg1-GFP3 also re-
mained in the cytoplasm in rapamycin-treated cells, indi-
cating that Rtg1 cannot accumulate in the nucleus in the
absence of Rtg3 (data not shown).
In striking contrast, we observed that Rtg3-GFP was lo-
calized exclusively in the nucleus in rtg1D cells, in both the
presence and absence of rapamycin (Fig. 7 B, bottom, and
data not shown). Thus, regulated transport of the Rtg1/
Rtg3 complex requires that both proteins be present to-
gether. One potential explanation to account for the con-
stitutive localization of these two proteins in different sub-
cellular compartments is that Rtg1 contains a nuclear
export signal, whereas Rtg3 contains the nuclear import
signal (NLS) for the heterodimer. Consistent with this in-
terpretation, a recent study has confirmed that the basic
domain of the bHLH motif of Rtg3 contains a functional
NLS (Sekito et al., 2000). Interestingly, however, we ob-
served that Rtg3 was also localized constitutively to the
nucleus when cells were deleted for both RTG1 and RTG2
(data not shown). Given that Rtg3 is localized exclusively
in the cytoplasm when cells are singly deleted for RTG2
(Fig. 7 A), together these results suggest that Rtg1 may
play a more antagonistic role in regulating Rtg3 nuclear
import. A similar conclusion has also been reached re-
cently by Sekito et al. (2000).
Export of Rtg1 and Rtg3 from the Nucleus Requires the 
b-Importin Homologue Msn5
Constitutive localization of Rtg3 in the nucleus in rtg1D
cells suggested that export of the Rtg1/Rtg3 complex from
the nucleus might play a role in the regulation of these
transcription factors. Previous studies of another nutrient-
responsive transcription factor, Pho4, has demonstrated
that its export from the nucleus depends on the activity of
Msn5, a member of the b-importin family of nuclear re-
ceptors (Kaffman et al., 1998a). We therefore tested
whether export of Rtg1 and Rtg3 might similarly be regu-
lated by this protein. Indeed, we observed that both Rtg1-
GFP and Rtg3-GFP were constitutively nuclear in msn5D
cells, demonstrating that this factor is required, either di-
rectly or indirectly, for export of the Rtg1/Rtg3 complex
from the nucleus (Fig. 8 A, left). Interestingly, when we
examined the localization of Rtg1-GFP and Rtg3-GFP in
msn5D rtg2D cells, both proteins remained in the cyto-
plasm, consistent with the above observation that Rtg2 is
Figure 7. Regulated nucleocytoplasmic transport of Rtg1 and
Rtg3 requires Rtg1, Rtg2, and Rtg3. (A) Rtg1-GFP and Rtg3-
GFP were visualized in rtg2D (EY0734) cells in the absence (left)
or presence (right) of rapamycin. In contrast to wild-type cells,
neither Rtg1-GFP nor Rtg3-GFP relocate to the nucleus after ra-
pamycin treatment (compare with Fig. 5 A). (B) Rtg1-GFP was
visualized in rtg3D (EY0735) cells (top) and Rtg3-GFP was visu-
alized in rtg1D (EY0733) cells (bottom). Note that Rtg1-GFP
cannot accumulate in the nucleus upon rapamycin treatment in
rtg3D cells. In contrast, Rtg3-GFP is localized constitutively to the
nucleus in rtg1D cells, even in the absence of rapamycin addition. 
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absolutely required for nuclear entry of the Rtg1/Rtg3
complex (Fig. 8 A, right). Additional control experiments
demonstrated that Rtg2-GFP remained in the cytoplasm
in msn5D cells (data not shown).
If regulated access to the nucleus represents the primary
mechanism by which the activity of the Rtg1/Rtg3 com-
plex is controlled, then we expected to observe constitu-
tive activation of their target genes in msn5D cells in the
absence of rapamycin. However, no such increased ex-
pression of RTG-target genes was observed in msn5D cells
compared with wild type (Fig. 8 B, compare lanes 1 and 3).
This observation is consistent with studies of other regu-
lated transcription factors; namely, that constitutive nu-
clear localization does not necessarily result in gene acti-
vation and that other regulatory mechanisms are involved
(Komeili and O’Shea, 1999). Remarkably, however, we
observed rapid induction of RTG-dependent target genes
in msn5D cells after addition of rapamycin (Fig. 8 B, com-
pare lanes 3 and 4). This latter result demonstrates that de-
spite its steady state nuclear localization in msn5D cells,
the Rtg1/Rtg3 complex remains responsive to changes in
TOR signaling. 
TOR-dependent Changes in the Phosphorylation State 
of Rtg3
Previous studies have demonstrated that changes in phos-
phorylation of a transcription factor can be important for
regulating its activity as well as concentration in the nu-
cleus (Beck and Hall, 1999; Komeili and O’Shea, 1999).
We therefore wished to determine whether rapamycin-
induced nuclear accumulation of Rtg1 and Rtg3 also cor-
related with changes in the phosphorylation state of either
of these proteins. Toward this end, we used immunoblot
analysis to monitor the electrophoretic mobility of these
proteins, as well as Rtg2, from extracts in which each pro-
tein was genomically tagged at its COOH terminus with
the HA3 epitope (see Materials and Methods). Extracts
were prepared from cells grown in rich nitrogen media
that had been incubated with drug vehicle alone or with
rapamycin, and then subsequently prepared in either the
presence or absence of phosphatase inhibitors. No change
in the relative abundance or mobility of Rtg1-HA3 or
Rtg2-HA3 was observed in untreated versus rapamycin-
treated cells (Fig. 9 A, lanes 1–4). In contrast, a slower mi-
grating form of Rtg3-HA3 appeared after addition of rapa-
mycin, which was observed only when extracts were
prepared in the presence of phosphatase inhibitors (Fig. 9
A, compare lanes 5 and 6, data not shown). These results
suggested that inhibition of TOR signaling resulted in a
change in the phosphorylation state of Rtg3.
We wanted to confirm that Rtg3 was a phosphoprotein
by treating purified Rtg3 with phosphatases in vitro; how-
ever, the HA epitope-tagged form of this protein was not
efficiently immunoprecipitated from cell extracts. We
therefore used a form of Rtg3 that was fused at its COOH
terminus to two z domains from Protein A, termed Rtg3-
zz, which could be immunoprecipitated quantitatively
from extracts using immobilized-IgG (data not shown).
The results confirmed that rapamycin treatment resulted
in the conversion of a portion of Rtg3-zz to a more slowly
migrating form (Fig. 9 B, compare lanes 1 and 2). More-
over, this slower form was abolished after treatment with
phosphatase, confirming that the rapamycin-induced change
in electrophoretic mobility of Rtg3-zz is due to changes in
phosphorylation (Fig. 9 B, compare lanes 2 and 4; arrow-
head, slower migrating form). Interestingly, the rapamy-
cin-induced shift in Rtg3 mobility was also observed in
rtg2D cells, suggesting that TOR influences Rtg3 phos-
phorylation independently from Rtg2 function (Fig. 9 B,
compare lanes 5 and 6).
While the above results demonstrate that TOR influ-
ences the phosphorylation state of Rtg3, several other re-
Figure 8. (A) Msn5 is required for export of Rtg1 and Rtg3 from
the nucleus. (A) msn5D (EY0736) and msn5D rtg2D (EY0744)
cells were transformed with pRtg1-GFP (top) or pRtg3-GFP
(bottom) and grown to 0.5 OD600/ml in SCD media lacking uracil
and were examined by fluorescence microscopy. Rtg1-GFP and
Rtg3-GFP were localized constitutively within the nucleus in
msn5D cells but not in msn5D rtg2D cells. (B) RTG-dependent
target genes remain responsive to TOR signaling in msn5D cells.
Wild-type (K699) and msn5D (EY0736) cells were grown in YPD
until 0.5 OD600/ml and were treated either with drug vehicle
(lanes 1 and 3) or with rapamycin (lanes 2 and 4) for 30 min (this
time of incubation corresponded to the peak induction of RTG-
dependent gene expression observed in the rapamycin time
course in Fig. 6). Cells were then harvested and RNA was pre-
pared and analyzed by Northern blotting, probing for the speci-
fied mRNAs.
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sults indicate that phosphorylation-dependent regulation
of this protein is likely to be complex. First, we observed
that Rtg3-zz was phosphorylated in the absence of rapa-
mycin treatment, a conclusion based on its increased mo-
bility after phosphatase treatment, suggesting that Rtg3 is
likely to be phosphorylated on multiple sites (Fig. 9 B,
compare lanes 1 and 3). The existence of multiple sites of
phosphorylation could account for the relatively poor res-
olution of Rtg3 on SDS-PAGE gels in the absence of
phosphatase treatment. Second, we were unable to detect
a difference in the mobility of Rtg3-zz in cells grown in
MD-glutamine versus MD-urea (Fig. 9 C, lanes 1 and 2).
This latter result suggests either that rapamycin-induced
changes are transient or that additional changes in the
phosphorylation state of this protein occur during steady
state growth of cells in media lacking glutamine. Finally,
multiple levels of regulation, possibly mediated by distinct
changes in the phosphorylation state of Rtg3, would be
consistent with our above observation that the Rtg1/Rtg3
complex is concentrated in the nucleus in msn5D cells, yet
their target genes remain uninduced. Identifying the resi-
due(s) of Rtg3 that are phosphorylated under these differ-
ent conditions will be required to resolve these issues.
Discussion
Genome-wide expression analysis represents a powerful
approach for exploring the scope of transcriptional regula-
tion associated with different biological processes. The
appeal of this method is most often attributed to the
enormous amount of information that it can yield, as ex-
emplified by studies in yeast of the diauxic shift, sporula-
tion, and the cell cycle, where each of these processes in-
volves sequential changes in the expression of groups of
coregulated genes that number well into the hundreds
(DeRisi et al., 1997; Chu et al., 1998; Spellman et al., 1998).
By contrast, our results presented here demonstrate that
by studying the effects of subtle changes in growth condi-
tions (e.g., by varying the source of assimilable nitrogen),
microarray analysis can help bring a specific biological
problem into sharper focus by identifying a concise set of
coregulated genes.
Specifically, we have demonstrated that a surprisingly
small number of genes are differentially expressed when
yeast cells use glutamine versus urea as their sole source of
nitrogen (Table II). All of these genes are either induced
or repressed by the presence of glutamine, a fact that is
consistent with its established importance as a major regu-
lator of nitrogen metabolism (Magasanik, 1992; Marzluf,
1997). One prominent group of glutamine-repressed genes
encodes proteins involved in the uptake and metabolism of
alternative sources of nitrogen, including urea and allan-
toin, and whose expression is controlled by the Gln3 and
Ure2 regulatory proteins (Coffman et al., 1997; Cox et al.,
1999). Recent studies have demonstrated that these genes
are negatively regulated by the TOR signaling pathway via
a mechanism that involves sequestration of the transcrip-
tion factor Gln3 in the cytoplasm (Beck and Hall, 1999).
A second prominent group of glutamine-repressed
genes encodes enzymes involved in the TCA and glyox-
ylate cycles and whose expression in urea-containing media
requires the heterodimeric transcription factors Rtg1 and
Rtg3. Differential expression of these metabolic genes is
consistent with the proposal by Liu and Butow (1999) that
one important role of RTG-dependent gene expression is
to provide adequate levels of a-ketoglutarate for use in
the de novo biosynthesis of glutamate, which in turn is re-
quired for the synthesis of glutamine. In addition, our re-
sults extend involvement of RTG-dependent regulation to
include PYC1, which provides an alternative route for the
synthesis of oxaloacetate for use in both the TCA cycle
and in amino acid biosynthesis (Fig. 3). These results thus
highlight the intimate relationship that exists between ni-
trogen and carbon metabolism as well as its importance to
normal cell growth.
Figure 9. Rtg3 is a phosphoprotein and is differentially phosphor-
ylated after rapamycin treatment. (A) Cells expressing Rtg1-HA3
(PLY047), Rtg2-HA3 (PLY089), and Rtg3-HA3 (PLY050) were
grown to 0.5 OD600/ml in YPD and were treated either with drug
vehicle alone or with rapamycin for 15 min. Extracts were pre-
pared and Western blot analysis was performed using anti–HA
monoclonal antibodies to detect each protein. No change in the
abundance or relative mobility of Rtg1 or Rtg2 could be detected
after rapamycin treatment. In contrast, a portion of Rtg3 showed
an increased mobility (arrowhead) after rapamycin treatment,
compared with its mobility in the absence of rapamycin (*). (B)
Wild-type (K699) and rtg2D (EY0734) cells transformed with
pRtg3-zz and were grown to 0.5 OD600/ml in SCD media lacking
uracil. Cells were then treated with drug vehicle or with rapamy-
cin for 15 min. Extracts were prepared and Rtg3-zz was immuno-
precipitated with IgG-Sepharose and either mock-treated or
treated with phosphatase before Western blot analysis, as indi-
cated. Increased mobility of a portion of Rtg3-zz after rapamcyin
treatment is indicated (arrowhead). (C) Wild-type (K699) cells
carrying pRtg3-zz were grown to 0.5 OD600/ml in MD-glutamine
or MD-urea and processed as in B. For each experiment in A–C,
all samples were from the same gel. Identical results were ob-
tained in three separate experiments.
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Remarkably, we find that TOR signaling also regulates
RTG-dependent gene activity. Specifically, inhibition of
the TOR kinases by rapamycin results in both rapid nu-
clear accumulation of the Rtg1/Rtg3 complex as well as in-
duction of their target genes. In addition, rapamycin treat-
ment correlates with changes in the phosphorylation state
of Rtg3, indicating that nucleocytoplasmic transport of the
complex is likely to be regulated by differential phosphor-
ylation of Rtg3. These results thus contribute to a growing
body of evidence demonstrating that one important role of
TOR is to control the activity of specific nutrient-respon-
sive transcription factors. Moreover, our findings suggest
that TOR signaling may provide an important mechanism
by which carbon and nitrogen use are linked. Whether
Rtg3 phosphorylation is influenced by the activity of the
Tap42-Sit4 phosphatase complex, as has been shown re-
cently for Gln3 (Beck and Hall, 1999), remains to be de-
termined.
Our results also shed light on the functional role of Rtg2
in regulating RTG-dependent gene expression, a previously
identified upstream positive regulator of Rtg1 and Rtg3
(Liao and Butow, 1993; Rothermel et al., 1997). Specifi-
cally, we find that Rtg2 is required for rapamycin-induced
entry of the Rtg1/Rtg3 complex into the nucleus (Fig. 10).
How Rtg2 acts mechanistically is unclear at present; how-
ever, we believe that Rtg2 is likely to be required for a step
subsequent to the action of TOR, based upon the observa-
tion that rapamycin-induced changes in Rtg3 phosphoryla-
tion are observed in rtg2D mutant cells (Fig. 8 B). Further-
more, our examination of Rtg3 localization in rtg1D, rtg2D,
and rtg1D rtg2D mutant cells suggests that Rtg2 may inter-
act primarily with Rtg1 to regulate nuclear entry of the
Rtg1/Rtg3 complex (Fig. 7, and data not shown).
In contrast to the role played by Rtg2, we find that
Msn5, a member of the importin-b family of nuclear trans-
port receptors, is required for nuclear export of the Rtg1/
Rtg3 complex (Fig. 10). Thus, in msn5D cells, both Rtg1
and Rtg3 are constitutively localized to the nucleus. We do
not know yet whether Msn5 interacts directly with Rtg1
and/or Rtg3 to facilitate their export from the nucleus, as
has been demonstrated for Pho4 (Kaffman et al., 1998). It
is possible that Msn5 is instead required for the proper lo-
calization of another protein(s) that is involved directly in
the export of the Rtg1/Rtg3 complex.
While nucleocytoplasmic transport of the Rtg1/Rtg3
complex is essential for regulated RTG-dependent gene
activation, our results indicate that additional control
mechanisms are involved. This conclusion is based on our
analyses of msn5D cells, where both Rtg1 and Rtg3 are
concentrated in the nucleus yet their target genes remain
uninduced (Fig. 9). As these genes can nevertheless be in-
duced rapidly in msn5D cells following rapamycin treat-
ment, these results raise the intriguing possibility that
TOR regulates Rtg1/Rtg3 activity in both the cytoplasm as
well as in the nucleus.
RTG1-RTG3 were originally identified as genes re-
quired for increased expression of CIT2 under conditions
where mitochondrial respiratory function is impaired, as in
rho0 petite mutants that lack mitochondrial DNA (Liao et
al., 1991; Liao and Butow, 1993). This process, termed ret-
rograde regulation, is believed to involve intracellular sig-
naling from the mitochondria to the nucleus (Liao and Bu-
tow, 1993). Subsequently, the RTG genes have been
shown to be involved in the expression of several genes
that encode peroxisomal proteins in addition to glyoxylate
cycle enzymes (Chelstowska and Butow, 1995; Kos et al.,
1995; McCammon, 1996; Liu and Butow, 1999). Indeed,
the results of these studies suggest that both mitochon-
drial and peroxisomal functions are intimately linked via
RTG-dependent gene expression. An important question
prompted by our present results thus concerns the rela-
tionship between TOR signaling and retrograde regula-
tion. While this manuscript was in preparation, Sekito et
al. (2000) reported that Rtg1 and Rtg3 are localized consti-
tutively to the nucleus in rho0 cells. Moreover, this local-
ization depends on a functional Rtg2 protein. Given these
similarities to what we present here, one possibility is that
TOR may be integrated with retrograde signaling.
At odds with this conclusion, however, is the finding
that nuclear accumulation of the Rtg1/Rtg3 complex in
rho0 cells appears to correlate with a substantial decrease
in phosphorylation of Rtg3 (Sekito et al., 2000). By con-
trast, our results suggest that nuclear import of this com-
plex after rapamycin treatment may coincide with in-
creased phosphorylation of Rtg3. Moreover, and very
importantly, we were unable to detect a difference in the
mobility of Rtg3 on SDS-PAGE following the growth of
cells in glutamine- versus urea-containing media (Fig. 9
C). Nevertheless, the Rtg1/Rtg3 complex is localized in
different subcellular compartments, cytoplasm versus nu-
cleus, under these different nitrogen conditions (Fig. 4).
Thus, the precise relationship between the phosphoryla-
Figure 10. Model for involvement of the TOR pathway in nitro-
gen-dependent regulation of the Rtg1 and Rtg3 transcription fac-
tors. See text for details.
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tion state of Rtg3 and its nucleocytoplasmic disposition
needs further clarification, which will require identifica-
tion of residues in Rtg3 that are subject to phosphoryla-
tion under different cellular conditions. At present, it thus
remains possible that retrograde and TOR signaling may
represent independent routes by which Rtg1 and/or Rtg3
are regulated and that both pathways ultimately converge
on the same nucleocytoplasmic transport step.
Inhibition of the TOR kinases by rapamycin affects the
expression of a large number of genes, including those reg-
ulated by nitrogen and glucose-sensitive signaling path-
ways, glycolytic genes, genes expressed during the diauxic
shift, and r-protein and rRNA genes (Beck and Hall, 1999;
Cardenas et al., 1999; Hardwick et al., 1999; Powers and
Walter, 1999; C. Kao, T. Powers, P. Walter, G. Crabtree,
P. Brown, unpublished observations). By contrast, we find
that only a small subset of these targets are expressed dif-
ferentially in our nitrogen source experiments, in particu-
lar the GLN3- and RTG-dependent genes described
above. These observations suggest that distinct branches
of the TOR pathway may be regulated independently ac-
cording to the precise nutritional state of the cell and,
moreover, suggest that TOR activity may be modulated by
multiple upstream nutritional signals. On the other hand,
many of the glutamine-regulated genes identified in this
study are affected to some extent by rapamycin treatment
(T. Powers, unpublished results). Thus, we believe that
TOR signaling is likely to represent an important mecha-
nism by which the availability of glutamine and/or glu-
tamate is coupled to changes in gene expression in eukary-
otic cells. One challenge now at hand is to understand how
TOR activity is regulated under different nitrogen condi-
tions. Such studies will undoubtedly prove invaluable to-
ward deciphering the role that this pathway plays in pro-
moting normal cell growth.
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